245 related articles for article (PubMed ID: 22157278)
1. Rituximab associated pneumonitis in antineutrophil cytoplasmic antibody-associated vasculitis.
Arulkumaran N; Suleman R; Cecconi M; Kiely P; Chua F
J Clin Rheumatol; 2012 Jan; 18(1):39-41. PubMed ID: 22157278
[TBL] [Abstract][Full Text] [Related]
2. Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis.
Smith RM; Jones RB; Guerry MJ; Laurino S; Catapano F; Chaudhry A; Smith KG; Jayne DR
Arthritis Rheum; 2012 Nov; 64(11):3760-9. PubMed ID: 22729997
[TBL] [Abstract][Full Text] [Related]
3. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
[TBL] [Abstract][Full Text] [Related]
4. Association of ANCA-associated vasculitis-rheumatoid arthritis overlap syndrome in four patients: rituximab may be the right choice?
Szilasi M; Mátyus J; File I; Szücs G; Rákóczi E; Pfliegler G; Szabó Z; Végh E; Szekanecz Z
Autoimmunity; 2012 Jun; 45(4):304-9. PubMed ID: 22443800
[TBL] [Abstract][Full Text] [Related]
5. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis.
Guillevin L; Pagnoux C; Karras A; Khouatra C; Aumaître O; Cohen P; Maurier F; Decaux O; Ninet J; Gobert P; Quémeneur T; Blanchard-Delaunay C; Godmer P; Puéchal X; Carron PL; Hatron PY; Limal N; Hamidou M; Ducret M; Daugas E; Papo T; Bonnotte B; Mahr A; Ravaud P; Mouthon L;
N Engl J Med; 2014 Nov; 371(19):1771-80. PubMed ID: 25372085
[TBL] [Abstract][Full Text] [Related]
6. B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study.
Martinez Del Pero M; Chaudhry A; Jones RB; Sivasothy P; Jani P; Jayne D
Clin Otolaryngol; 2009 Aug; 34(4):328-35. PubMed ID: 19673980
[TBL] [Abstract][Full Text] [Related]
7. Rituximab in ANCA-associated vasculitis: fad or fact?
Fervenza FC
Nephron Clin Pract; 2011; 118(2):c182-8; discussion c188. PubMed ID: 21160229
[TBL] [Abstract][Full Text] [Related]
8. Refractory disease in antineutrophil cytoplasmic antibodies associated vasculitis.
Rutgers A; Kallenberg CG
Curr Opin Rheumatol; 2012 May; 24(3):245-51. PubMed ID: 22410545
[TBL] [Abstract][Full Text] [Related]
9. [Severe Wegener's granulomatosis successfully treated with rituximab].
Semenkova EN; Krivosheev OG; Novikov PI; Osipenko VI; Nosova NR; Parfenova SA; Nikiforova NV; Borodin OO
Ter Arkh; 2010; 82(6):53-5. PubMed ID: 20731113
[TBL] [Abstract][Full Text] [Related]
10. Rituximab treatment for vasculitis.
Jayne D
Clin J Am Soc Nephrol; 2010 Aug; 5(8):1359-62. PubMed ID: 20671223
[No Abstract] [Full Text] [Related]
11. S3. Rituximab for ANCA-associated vasculitides: the French experience.
Charles P; Guillevin L
Presse Med; 2013 Apr; 42(4 Pt 2):534-6. PubMed ID: 23453207
[No Abstract] [Full Text] [Related]
12. [The role of rituximab in the treatment of ANCA-associated systemic vasculitis].
Roccatello D; Vangelista A; Pani A
G Ital Nefrol; 2011; 28(5):474-88. PubMed ID: 22028261
[TBL] [Abstract][Full Text] [Related]
13. Antineutrophil cytoplasmic antibody-associated vasculitis complicated with diffuse alveolar hemorrhage: a study of 12 cases.
Lin Y; Zheng W; Tian X; Zhang X; Zhang F; Dong Y
J Clin Rheumatol; 2009 Oct; 15(7):341-4. PubMed ID: 20009969
[TBL] [Abstract][Full Text] [Related]
14. Refractory antineutrophil cytoplasmic antibody-associated vasculitis successfully treated with rituximab: a case report.
Horai Y; Miyamura T; Takahama S; Hirata A; Nakamura M; Ando H; Minami R; Yamamoto M; Suematsu E
Nihon Rinsho Meneki Gakkai Kaishi; 2010; 33(2):105-10. PubMed ID: 20453447
[TBL] [Abstract][Full Text] [Related]
15. [Experience with rituximab treatment (monoclonal antibodies to B-lymphocyte CD20 receptors) of Wegener's granulomatosis patients with renal impairment].
Novikov PI; Krivosheev OG; Semenkova EN
Ter Arkh; 2011; 83(11):70-6. PubMed ID: 22312891
[TBL] [Abstract][Full Text] [Related]
16. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis with rituximab.
Cartin-Ceba R; Fervenza FC; Specks U
Curr Opin Rheumatol; 2012 Jan; 24(1):15-23. PubMed ID: 22089095
[TBL] [Abstract][Full Text] [Related]
17. S2. Rituximab for ANCA-associated vasculitis: the UK experience.
Jayne D
Presse Med; 2013 Apr; 42(4 Pt 2):532-4. PubMed ID: 23490639
[No Abstract] [Full Text] [Related]
18. Wegener granulomatosis (granulomatosis with polyangiitis): evolving concepts in treatment.
Lynch JP; Tazelaar H
Semin Respir Crit Care Med; 2011 Jun; 32(3):274-97. PubMed ID: 21674414
[TBL] [Abstract][Full Text] [Related]
19. Tubular lesions predict renal outcome in antineutrophil cytoplasmic antibody-associated glomerulonephritis after rituximab therapy.
Berden AE; Jones RB; Erasmus DD; Walsh M; Noël LH; Ferrario F; Waldherr R; Bruijn JA; Jayne DR; Bajema IM;
J Am Soc Nephrol; 2012 Feb; 23(2):313-21. PubMed ID: 22095945
[TBL] [Abstract][Full Text] [Related]
20. Rituximab for rescue and maintenance therapy in rapidly progressive life-threatening antineutrophil cytoplasmic autoantibody-associated systemic vasculitis.
José RJ; Chrysochou C; Shurrab AE; New D; Wood GN
Scand J Urol Nephrol; 2010 Dec; 44(6):459-62. PubMed ID: 20645677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
